Insight Partners

Activity from announced rounds

Activity in this selectionSeries B

Insight Partners invests in software companies from early stages through growth and later-stage expansion, with an operating team focused on the work of scaling a software business.

Its Onsite team provides specialist support in hiring, marketing, product, acquisitions and international expansion. Founders can work with operators on questions such as building a sales organisation, recruiting leadership and improving growth efficiency.

Insight’s model is particularly relevant when a company is turning product-market fit into a repeatable business. Its investment platform can address both the capital needed for expansion and the organisational changes that accompany it.

Sources
Rounds participated in
12
Confirmed lead rounds
6
4 roles undisclosed
New companies
12
First participation on record · 0 follow-on
Funding in participating rounds
$767.5M
12 disclosed · full round size, not this investor’s share

By stage

Series B12

By primary sector

AI2
Defense tech2
Enterprise software2
Fintech2
Biotech1
3 more
Climate tech1
Cybersecurity1
Developer tools1

By country

United States10
Australia1
Netherlands1

Rounds

12 in this selection
Stuut

AI software for finance teams that follows up on invoices, resolves payment disputes and matches incoming payments to receivables.

$52.5MSeries B
Lead
Quartermaster

Equips ships with sensor packages and analytics to create a distributed real-time maritime intelligence network

$140MSeries B equity + debt facility
Lead
Confido

Confido connects accounting, finance, sales and operations data so consumer brands can manage deductions, trade spending and supply plans together.

$55MSeries B
Lead
Luzern Risk

A captive-insurance manager and technology platform that helps businesses form, operate and monitor insurance companies they own.

$45MSeries B
Lead
BackOps

BackOps coordinates supply-chain exceptions across enterprise systems, carriers, suppliers and distributors.

$42MSeries B
Lead
Superluminal Medicines

Superluminal Medicines combines structural biology, protein dynamics, machine learning and experimental testing to discover small-molecule drugs for difficult G protein-coupled receptor targets. Its pipeline focuses on endocrine and cardiometabolic diseases, including rare genetic and hypothalamic obesity.

$60MSeries B
Participant
Gridsight

Gridsight builds an AI capacity-management platform for electricity utilities.

$26MSeries B
Lead
Easy Aerial

Autonomous tethered and drone-in-a-box systems for aerial surveillance and inspection.

$20MSeries B
Participant
Convex

Convex provides a reactive backend with database, functions, workflow, and storage.

$57MSeries B
Role not disclosed
DataBahn

Agentic Data Control Plane for the enterprise

$40MSeries B
Role not disclosed
Wonderful

Wonderful provides an enterprise AI platform for connected workflows, applications and agents.

$150MSeries B
Role not disclosed
Jump

Provides AI-powered features to reduce busywork for financial advisors and surface growth insights

$80MSeries B
Role not disclosed